Ballentine Partners’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.7M Buy
69,885
+645
+0.9% +$42.2K 0.07% 100
2026
Q1
$3.17M Sell
69,240
-525
-0.8% -$30.3K 0.04% 142
2025
Q4
$5.19M Sell
69,765
-1,711
-2% -$123K 0.07% 96
2025
Q3
$5.22M Sell
71,476
-4,546
-6% -$346K 0.07% 92
2025
Q2
$5.26M Sell
76,022
-246
-0.3% -$12.8K 0.08% 89
2025
Q1
$3.45M Buy
76,268
+72,186
+1,768% +$4.28M 0.06% 112
2024
Q4
$249K Buy
+4,082
New +$227K ﹤0.01% 684

Other funds holding AFRM

Ballentine Partners's AFRM Position: Q2 2026 in Review

Ballentine Partners increased its Affirm (AFRM) stake by 0.93% in Q2 2026, buying an estimated $42.2K and bringing the position to 69,885 shares worth $5.7M. The position accounts for 0.07% of the portfolio, ranked #100.

Ballentine Partners first reported a position in AFRM in Q4 2024 and has held it in 7 quarters since. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Ballentine Partners held 69,885 shares of Affirm worth $5.7M as of Q2 2026.
  • Ballentine Partners bought 645 Affirm shares in Q2 2026, an estimated $42.2K.
  • Affirm made up 0.07% of Ballentine Partners's portfolio in Q2 2026, its #100 holding.
  • Ballentine Partners first reported a position in Affirm in Q4 2024 and has held it in 7 quarters since.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.